# Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC

> **NCT00268684** · PHASE3 · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 381 (—)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung
- Neoplasm Metastasis

## Interventions

- **DRUG:** Erlotinib, Temozolomide

## Key facts

- **NCT ID:** NCT00268684
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 381 (—)
- **Last updated:** 2006-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00268684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00268684, "Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT00268684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*